Regarding “A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion”  by Takagi, Hisato et al.
LETTERS TO THE EDITOR
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iRegarding “Aneurysmal iliac arteries do not portend
future iliac aneurysmal enlargement after
endovascular aneurysm repair for abdominal aortic
aneurysm”
The article by Kirkwood et al, “Aneurysmal iliac arteries do
not portend future iliac aneurysmal enlargement after endovascular
aneurysm repair for abdominal aortic aneurysm,”1 raises a perti-
nent question. I believe there are two methodological issues that
may affect the study’s validity.
(1)The main outcome is “common iliac artery (CIA) dilation
 5 mm.” This event is clearly a time-dependent outcome: the risk
of a patient having one of its CIAs dilating beyond a certain
threshold depends on the time such patient is exposed. In this case,
on the follow-up time after aneurysm repair. Although details on
subject follow-up time were not reported, by the type of study one
may infer that we are dealing with staggered data (patients entering
the study at different time-points, thus being followed during
uneven lengths of time). This clearly implies that one cannot
compare the frequency of this outcome between both groups
simply by calculating proportions and testing differences with 2 or
Fisher exact test, as reported. The use of survival analysis tech-
niques (usually Kaplan–Meier curves, testing for differences with
the log-rank test) is mandatory. Reporting a similar mean
follow-up time between both groups of exposure does not justify
using a methodology appropriate for time-independent outcomes.
Other outcomes (secondary interventions and aneurysm-related
mortality) were rightfully analyzed.
(2) The objective was stated as “. . .examine the fate of aneu-
rysmal iliac arteries during endovascular aneurysm repair. . .” Two
groups were defined (with or without baseline iliac aneurysms) and
compared. Iliac management was not uniform, although some
patients had hypogastric embolization with graft extension to the
external iliac artery, while in others, a flared limb extension was
used. Furthermore, the frequency of such techniques was signifi-
cantly different between both groups of exposure (with or without
ectatic baseline iliacs), P .01. When defining two groups for
comparison, one should ensure they remain as uniform as possible,
except for the variable at stake. Such comparability should be
especially checked for variables presumably associated with the
studied outcome.
After considering both these issues, I do not think we can
easily accept the conclusion “. . .current techniques for endovas-
cular management of concurrent CIA aneurysms do not predis-
pose to future growth of these vessels” as a valid one. I would much
appreciate the authors’ feedback.
Sergio M. Sampaio MD, PhD
Department of Vascular Surgery
Hospital S. Joao
Porto, Portugal
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We appreciate the letter by Dr Sampaio and agree that if the
tudy had been run in the manner stated in his letter, then the
ssertion regarding the statistical analysis would be correct; how-
ver, in this trial, each patient in the study came back for evalua-
ions at regularly scheduled time intervals, scheduled after each
ndividual’s aneurysm repair. Since each patient was observed at
he same intervals, the comparison performed is appropriate in this
ase. The mean follow-up was provided not as a justification for the
nalysis method, but as another element of homogeneity between
he groups of interest. To address Dr Sampaio’s second point
egarding the nonuniformity of iliac artery management, the au-
hors agree that those patients treated with external iliac extensions
ould have been removed from the calculations; however, with
uch a small proportion of patients in the study to whom this
ould apply, it was felt best to analyze the two groups as a whole.
elissa L. Kirkwood, MD
niversity of Pennsylvania Health System
ivision of Vascular Surgery and Endovascular Therapy
hiladelphia, Pa
oi:10.1016/j.jvs.2011.06.014
egarding “A meta-analysis of clinical studies of
tatins for prevention of abdominal aortic aneurysm
xpansion”
Our previous meta-analysis1 of five studies showed that statin
herapy was associated with lower expansion rates in patients with
mall abdominal aortic aneurysm (AAA) (pooled random-effects
tandardized mean difference, 0.50; 95% confidence interval
CI], 0.75 to 0.25; P  .0001; P for heterogeneity  .03),
hich suggests that statins may reduce AAA expansion. The major
imitation of our study, however, was that we combined only
bservational studies. Because the treatment strategy was not
ased on randomized assignment, our findings were subject to
election bias and confounding. To minimize these biases,
chlösser et al2 and Schouten et al3 used a multivariate linear
egression model and provided not unadjusted but adjusted mean
ifferences (MDs) of AAA expansion rates with 95% CIs between
tatin and control groups. From the other three studies, we were
ble to abstract only crude means and standard deviations in both
roups. In nonrandomized observational studies, it is always nec-
ssary to adjust for confounding, otherwise, the results are subject
o some degree of bias. We performed herein an updated meta-
nalysis pooling only adjusted MD of AAA expansion rate between
tatin and control groups.
We searched literature through April 2011 with the same
trategy and inclusion criteria as those of our previous meta-
nalysis.1 Our search identified four risk-adjusted observational
tudies.2-5 Pooled analysis demonstrated statistically significant
ower expansion rate with statin therapy relative to control (pooled
andom-effects MD, 0.72 mm/y; 95% CI, 1.41 to 0.04
m/y; P  .04; P for heterogeneity  .03; Table).
Despite debates in their Letters to the Editor by Hurks et al6
nd Ferguson et al7 regarding our previous meta-analysis,1 we
ound that, based on a meta-analysis of only risk-adjusted observa-
ional studies, statin therapy is associated with less expansion rates
n patients with small AAA, which is strengthened by the results of
8he most recent meta-analysis by Twine and Williams of seven
bservational studies. Nevertheless, hidden bias may remain be-
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Volume 54, Number 5 Letters to the Editor 1553cause of the influence of unmeasured confounders even after
appropriate adjustment. To confirm the present results and more
accurately assess the effect of statins on AAA expansion, a large
randomized trial is needed.
Hisato Takagi, MD, PhD
Hirotaka Yamamoto, MD
Shin-nosuke Goto, MD
Masafumi Matsui, MD
Takuya Umemototo, MD, PhD
Department of Cardiovascular Surgery
Shizuoka Medical Center, Shizuoka, Japan
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Table. Risk-adjusted observational studies included in the
Study No. Mean follow-up, years Adjust
Schlösser
(2008)2
147 4.0  2.5 Age, sex, diamet
cardiovascular
with a P value
with univariate
regression
Schouten
(2006)3
150 Median,
3.1(range, 1.1-13.1)
Age, gender, dia
use, and, cardi
factors, weight
number of obs
Sweeting
(2010)4
1556 5.3 Age, sex, diamet
status, IHD, A
history of hype
each of the oth
categories
Thompson
(2010)5
1197 Median,
3.4(IQR, 2.0-6.5)
Curvature, diam
gender, smoki
variables for d
Total 3050
ABPI,Ankle-brachial pressure index;CI, confidence interval;NSAID, non-st
pressure; IQR, interquartile range.doi:10.1016/j.jvs.2011.05.113
p
regarding “Effect of gender on long-term survival
fter abdominal aortic aneurysm repair based on
esults from the Medicare national database”
Egorova et al1 compared long-term survival of propensity score-
atched cohorts of endovascular (EVAR) and open aneurysm repair
OAR) for abdominal aortic aneurysm (AAA) from the Medicare Bene-
ciary Database. The survival benefit of EVAR for elective AAA was
ustained for the 6-year follow-up in both men (hazafor the 6-year
ollowrd ratio [HR], 0.96; 95% confidence interval [CI], 0.93-0.99;P
0049) and women (HR, 0.88; 95% CI, 0.83-0.93; P  .0001). In a
ecent meta-analysis by Lovegrove et al2 of three randomized controlled
rials (RCTs) and eight observational comparative studies, however,
VAR for elective AAA was not associated with a reduction in long-term
ll-cause mortality (HR, 0.94; 95% CI, 0.79-1.13;P .52). The authors
xtracted unadjusted HRs from crude Kaplan-Meier survival curves3 in
bservational studies except for two studies (reporting an unadjusted HR
n one and an adjusted odds ratio in another). We performed herein a
eta-analysis of RCTs and risk-adjusted observational studies (providing
djusted-risk estimates for follow-up all-cause death) of elective EVAR
ersus OAR for unruptured AAAs.
The MEDLINE and EMBASE databases and the Cochrane
ibrary and Central Register of Controlled Trials were searched using
ubMed and OVID. Text keywords included elective, electively,
onacute, nonurgent, nonemergent, unruptured, or intact; endovas-
ular, endovascularly, stent, endograft, or endoprosthesis; open, con-
entional, conventionally, surgical, surgically; abdominal aortic aneu-
ysm; randomized, randomly, or randomization; and adjusted,
djustment, multivariate, multivariable, multiple, Cox, hazard, logis-
ic, regression, or propensity. Studies considered for inclusion met the
ollowing criteria: the design was an RCT or risk-adjusted observa-
ional comparative study; acceptable risk-adjustment methods in-
luded propensity score analyses, multivariate Cox proportional haz-
rds regression models, and multivariate logistic regression models;
he study population was patients with unruptured AAAs; patients
ere assigned to elective EVAR versus OAR; and main outcomes
ncluded follow-up (1 year) all-cause mortality.
Our search through April 2011 identified five RCTs and nine
isk-adjusted observational studies. Risk-adjustment methods were pro-
ent meta-analysis
Weight
Adjusted
mean
difference,
mm/y 95% CI P value
d
actors
alculated
r
19.4% 1.20 2.30 0.06 .039
, NSAID
ular risk
ith the
ions
25.2% 1.16 1.99 0.33 .006
oking
diabetes,
ion, and
ug
20.1% 0.90 1.98 0.18 .106
AP, age,
story, and
tegories
35.3% 0.07 0.45 0.32 .73
100.0% 0.72 1.41 0.04 .04
l anti-inflammatory drugs; IHD, ischemic heart disease;MAP,mean arterialpres
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eroidaensity score analyses in five, multivariate Cox proportional hazards
egression models in three, and multivariate logistic regression models in
